Latest Industry Insights

In this interview, Sudharshan Rangarajan discusses how laboratories can overcome some of the hurdles of incorporating automation into their workflow and highlights some of the solutions that Thermo Fisher Scientific offers in this space.

Technology Networks spoke with Dr. Ben Hindson, co-founder and chief scientific officer of 10x Genomics, to learn more about the challenges of conducting single-cell analyses in space and how terrestrial single-cell methods will be adapted for use in space.

To learn how cell cultured human milk is produced and how it compares to mothers’ milk, Technology Networks spoke to Shayne Guiliano, CEO of 108Labs. In this interview, Shayne also highlights the impact that scaling up the technology will have and shares his thoughts on what could be in store for the future of cellular agriculture.

There is increasing interest in finding and applying prediction models that are more physiologically relevant to humans, in particular those which can be used for the safety assessment of new drug candidates in more vulnerable patients. Rather than starting from a healthy animal or using animal models of disease, the use of patient tissues represents a major step forward.

In this interview, Dr. George Emanuel discusses some of the most exciting findings from the Mouse Receptor Map and highlights how the datasets will benefit the Human Cell Atlas project.

Multi-dimensional insights into the effects of drugs on protein structure and function can help de-risk the drug discovery process, building confidence in new drug candidates and their mechanism of action before moving on to the next more costly stage of development.

Technology Networks spoke to John Moore, president of Scientific Bioprocessing to find out more about the monitoring of cell cultures in real-time using optical sensors.

To learn more about the causes and consequences of peripheral nerve damage and some of the solutions available to patients, Technology Networks spoke with Karen Zaderej, chief executive officer of Axogen.

Technology Networks spoke to Dr. Giulia Kennedy, chief scientific officer and chief medical officer for Veracyte, to learn more about the Percepta Genomic Atlas and nasal swab tests for the diagnosis of lung cancer.

Women’s Health Access Matters recently released The WHAM Report, outlining new research conducted by the RAND Corporation to study the impact of accelerating sex- and gender-based AD, heart and autoimmune research on women, their families and the economy. To learn more about the report, the recently released AD findings and their significance, we spoke to Carolee Lee, founder and CEO of WHAM.